Valuation: Ovation Science Inc.

Market Cap 11.53L 8L 7L 7L 6L 7.79Cr 11.68L 81.09L 31.21L 3.98Cr 30.5L 29.84L 13Cr P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 13.64L 10L 8L 8L 7L 9.21Cr 13.82L 95.91L 36.91L 4.71Cr 36.08L 35.29L 15Cr EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.56%
Yield 2024 *
-
Yield 2025 -
1 day-79.67%
3 months-78.57%
6 months-64.62%
Current year-74.58%
Current year 0.01
Extreme 0.007
0.08
1 year 0.01
Extreme 0.007
0.08
3 years 0.01
Extreme 0.007
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 30/10/2023
Chief Executive Officer 77 04/10/2017
Director TitleAgeSince
Director/Board Member 77 04/10/2017
Director/Board Member 63 04/10/2017
Director/Board Member 86 02/02/2018
Change 5-day change 1-year change 3-year change Capi.($)
-79.67%-.--% - - 8L
-2.05%-1.43%-5.45%-0.40% 34TCr
-1.55%-2.90%+1.95%-5.13% 23TCr
-1.86%-3.85%-7.96%-0.01% 13TCr
-1.32%-0.71%+6.73%+19.98% 6.8TCr
-0.68%+1.42%+22.16% - 4.64TCr
-2.19%-4.89%-27.49%-25.52% 4.6TCr
-1.40%-0.06%+8.81%-12.05% 3.39TCr
-1.70%-6.13%+5.28%-35.82% 3.36TCr
-1.58%-0.28%-21.64%-19.38% 3.24TCr
Average -9.40%-1.18%-1.96%-9.79% 10.65TCr
Weighted average by Cap. -1.75%-1.08%-2.55%-3.69%

Financials

2024 2025
Net sales 1L 79.75T 70.23T 66.54T 60.07T 76.46L 1L 8L 3L 39.09L 3L 3L 1.25Cr 67.89T 47.82T 42.11T 39.9T 36.02T 45.85L 68.76T 5L 2L 23.44L 2L 2L 75.15L
Net income -5L -3L -3L -3L -2L -3.08Cr -5L -32.08L -12.34L -1.58Cr -12.07L -11.8L -5.05Cr -6L -4L -4L -4L -3L -4.26Cr -6L -44.39L -17.08L -2.18Cr -16.7L -16.33L -6.99Cr
Net Debt 3L 2L 2L 2L 1L 1.79Cr 3L 18.65L 7L 91.56L 7L 7L 2.94Cr 2L 1L 1L 1L 1L 1.42Cr 2L 14.82L 6L 72.77L 6L 5L 2.33Cr
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-